» Articles » PMID: 15264276

Genomic Imprinting and Environment in Hereditary Paraganglioma

Overview
Specialty Genetics
Date 2004 Jul 21
PMID 15264276
Citations 16
Authors
Affiliations
Soon will be listed here.
Abstract

Hereditary paraganglioma (PGL) is characterized by the development of slow-growing and vascularized tumors in the paraganglionic system. PGL is caused by germ line heterozygous inactivating mutations in the SDHB (PGL4), SDHC (PGL3), or SDHD (PGL1) genes, which encode three of the four subunits of mitochondrial complex II (succinate dehydrogenase; SDH). Common tumor sites include the carotid body in the neck and paraganglia in the abdomen. The risk of tumor development associated with SDHD mutations is determined by the sex of the transmitting parent, because only a paternal transmission leads to tumorigenesis in the progeny. This transmission pattern suggests operation of genomic imprinting on the SDHD gene. There is also evidence that the risk of tumor development increases at higher altitudes among SDHD mutation carriers. Accordingly, the increased prevalence of SDHD mutations in the Netherlands, attributable to multiple founder mutations, has been explained in part by the low altitudes in this country, which presumably reduce gene penetrance and relax the natural selection. Thus, PGL caused by SDHD mutations represents an unusual example of an inherited monogenic tumor syndrome because the risk of tumorigenesis shows an absolute dependence on the sex of the transmitting parent and may be modified by a ubiquitous environmental factor.

Citing Articles

A need to tailor surveillance based on family history: describing a highly penetrant familial paraganglioma kindred with an SDHD pathogenic variant.

Foley M, Sharma A, Garfield K, Maese L, Buchmann L, Boyle J Fam Cancer. 2022; 22(2):217-224.

PMID: 36223042 DOI: 10.1007/s10689-022-00318-9.


Succinate dehydrogenase inversely regulates red cell distribution width and healthy life span in chronically hypoxic mice.

Baysal B, Alahmari A, Rodrick T, Tabaczynski D, Curtin L, Seshadri M JCI Insight. 2022; 7(17).

PMID: 35881479 PMC: 9536274. DOI: 10.1172/jci.insight.158737.


Prevalence of Germline Variants in a Large Cohort of Japanese Patients with Pheochromocytoma and/or Paraganglioma.

Yonamine M, Wasano K, Aita Y, Sugasawa T, Takahashi K, Kawakami Y Cancers (Basel). 2021; 13(16).

PMID: 34439168 PMC: 8394264. DOI: 10.3390/cancers13164014.


Incomplete penetrance of a novel SDHD variation causing familial head and neck paraganglioma.

Koenighofer M, Parzefall T, Frohne A, Frei E, Schoefer C, Laccone F Clin Otolaryngol. 2021; 46(5):1044-1049.

PMID: 33851515 PMC: 8453574. DOI: 10.1111/coa.13782.


A novel mutation in the succinate dehydrogenase subunit D gene in siblings with the hereditary paraganglioma-pheochromocytoma syndrome.

Prasad C, Oakley 3rd G, Yip L, Coyne C, Rangaswamy B, Dixit S SAGE Open Med Case Rep. 2016; 2:2050313X14553520.

PMID: 27489656 PMC: 4857366. DOI: 10.1177/2050313X14553520.